nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP3A4—type 2 diabetes mellitus	0.243	1	CbGaD
Astemizole—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0498	0.078	CbGbCtD
Astemizole—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0498	0.078	CbGbCtD
Astemizole—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0497	0.078	CbGbCtD
Astemizole—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0443	0.0695	CbGbCtD
Astemizole—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0373	0.0585	CbGbCtD
Astemizole—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0321	0.0503	CbGbCtD
Astemizole—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0302	0.0474	CbGbCtD
Astemizole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0298	0.0467	CbGbCtD
Astemizole—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0279	0.0437	CbGbCtD
Astemizole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0266	0.0417	CbGbCtD
Astemizole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0243	0.0381	CbGbCtD
Astemizole—CYP3A5—Losartan—type 2 diabetes mellitus	0.0231	0.0362	CbGbCtD
Astemizole—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0229	0.0359	CbGbCtD
Astemizole—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.022	0.0345	CbGbCtD
Astemizole—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0219	0.0344	CbGbCtD
Astemizole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0212	0.0333	CbGbCtD
Astemizole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0192	0.0301	CbGbCtD
Astemizole—ABCB1—Glyburide—type 2 diabetes mellitus	0.0164	0.0257	CbGbCtD
Astemizole—ABCB1—Losartan—type 2 diabetes mellitus	0.015	0.0235	CbGbCtD
Astemizole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0146	0.0228	CbGbCtD
Astemizole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.014	0.0219	CbGbCtD
Astemizole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.014	0.0219	CbGbCtD
Astemizole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0132	0.0207	CbGbCtD
Astemizole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00983	0.0154	CbGbCtD
Astemizole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00899	0.0141	CbGbCtD
Astemizole—CYP2J2—artery—type 2 diabetes mellitus	0.00221	0.195	CbGeAlD
Astemizole—Flunarizine—CALM1—type 2 diabetes mellitus	0.00126	0.267	CrCbGaD
Astemizole—Pimozide—CALM1—type 2 diabetes mellitus	0.00116	0.246	CrCbGaD
Astemizole—CYP2J2—nephron tubule—type 2 diabetes mellitus	0.000854	0.0753	CbGeAlD
Astemizole—CYP2J2—cardiovascular system—type 2 diabetes mellitus	0.000767	0.0676	CbGeAlD
Astemizole—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000726	0.064	CbGeAlD
Astemizole—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.000703	0.149	CrCbGaD
Astemizole—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000621	0.0548	CbGeAlD
Astemizole—CYP3A7—liver—type 2 diabetes mellitus	0.000474	0.0418	CbGeAlD
Astemizole—CYP2J2—liver—type 2 diabetes mellitus	0.000474	0.0418	CbGeAlD
Astemizole—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000452	0.0398	CbGeAlD
Astemizole—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000403	0.0355	CbGeAlD
Astemizole—Flunarizine—CYP1A2—type 2 diabetes mellitus	0.000396	0.0839	CrCbGaD
Astemizole—Pimozide—CYP2E1—type 2 diabetes mellitus	0.000383	0.0813	CrCbGaD
Astemizole—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000373	0.0329	CbGeAlD
Astemizole—Pimozide—CYP1A2—type 2 diabetes mellitus	0.000365	0.0774	CrCbGaD
Astemizole—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000327	0.0288	CbGeAlD
Astemizole—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.0003	0.0265	CbGeAlD
Astemizole—CYP3A5—kidney—type 2 diabetes mellitus	0.000264	0.0233	CbGeAlD
Astemizole—CYP3A5—pancreas—type 2 diabetes mellitus	0.000262	0.0231	CbGeAlD
Astemizole—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000257	0.0227	CbGeAlD
Astemizole—Pimozide—CYP3A4—type 2 diabetes mellitus	0.000241	0.0512	CrCbGaD
Astemizole—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000238	0.021	CbGeAlD
Astemizole—HRH1—adipose tissue—type 2 diabetes mellitus	0.000231	0.0204	CbGeAlD
Astemizole—Fentanyl—CYP3A4—type 2 diabetes mellitus	0.000209	0.0444	CrCbGaD
Astemizole—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000198	0.0175	CbGeAlD
Astemizole—CYP3A4—kidney—type 2 diabetes mellitus	0.000198	0.0175	CbGeAlD
Astemizole—CYP2D6—kidney—type 2 diabetes mellitus	0.000195	0.0172	CbGeAlD
Astemizole—ABCB1—retina—type 2 diabetes mellitus	0.000169	0.0149	CbGeAlD
Astemizole—CYP3A5—liver—type 2 diabetes mellitus	0.000167	0.0147	CbGeAlD
Astemizole—ABCB1—nephron tubule—type 2 diabetes mellitus	0.00016	0.0141	CbGeAlD
Astemizole—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000143	0.0126	CbGeAlD
Astemizole—ABCB1—kidney—type 2 diabetes mellitus	0.00014	0.0124	CbGeAlD
Astemizole—ABCB1—pancreas—type 2 diabetes mellitus	0.000139	0.0123	CbGeAlD
Astemizole—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000137	0.012	CbGeAlD
Astemizole—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000126	0.0111	CbGeAlD
Astemizole—CYP3A4—liver—type 2 diabetes mellitus	0.000125	0.011	CbGeAlD
Astemizole—CYP2D6—liver—type 2 diabetes mellitus	0.000123	0.0109	CbGeAlD
Astemizole—ABCB1—liver—type 2 diabetes mellitus	8.87e-05	0.00782	CbGeAlD
Astemizole—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.12e-05	0.000109	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.11e-05	0.000108	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.11e-05	0.000108	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	1.11e-05	0.000108	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	1.11e-05	0.000108	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.1e-05	0.000107	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.1e-05	0.000107	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.1e-05	0.000107	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.1e-05	0.000107	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.1e-05	0.000107	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.09e-05	0.000106	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.09e-05	0.000106	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	1.08e-05	0.000105	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.08e-05	0.000105	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.08e-05	0.000105	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.08e-05	0.000105	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.08e-05	0.000105	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.07e-05	0.000104	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	1.06e-05	0.000103	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.06e-05	0.000103	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.06e-05	0.000103	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.06e-05	0.000103	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.05e-05	0.000102	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.04e-05	0.000101	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.04e-05	0.000101	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.04e-05	0.000101	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.04e-05	0.000101	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	1.03e-05	0.0001	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.02e-05	9.91e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.02e-05	9.91e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.02e-05	9.9e-05	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.02e-05	9.9e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.02e-05	9.87e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.02e-05	9.87e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.01e-05	9.85e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.01e-05	9.85e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.01e-05	9.85e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	1.01e-05	9.84e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	1.01e-05	9.8e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.01e-05	9.79e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.99e-06	9.7e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	9.98e-06	9.69e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	9.9e-06	9.61e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.82e-06	9.53e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.82e-06	9.53e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.82e-06	9.53e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	9.79e-06	9.5e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.66e-06	9.38e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.66e-06	9.37e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.66e-06	9.37e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.66e-06	9.37e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.57e-06	9.29e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	9.56e-06	9.28e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.56e-06	9.28e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	9.52e-06	9.24e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	9.48e-06	9.2e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.44e-06	9.17e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	9.44e-06	9.17e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.4e-06	9.13e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	9.39e-06	9.12e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	9.39e-06	9.12e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.36e-06	9.09e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.26e-06	8.99e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.23e-06	8.96e-05	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.21e-06	8.94e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.19e-06	8.92e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	9.13e-06	8.86e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	9.12e-06	8.85e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9.1e-06	8.83e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9.1e-06	8.83e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9.1e-06	8.83e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.09e-06	8.82e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.98e-06	8.72e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	8.93e-06	8.67e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	8.87e-06	8.61e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	8.85e-06	8.59e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.83e-06	8.57e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	8.79e-06	8.54e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.73e-06	8.48e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.73e-06	8.48e-05	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—AKT1—type 2 diabetes mellitus	8.72e-06	8.47e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	8.71e-06	8.46e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	8.71e-06	8.45e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	8.66e-06	8.41e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.65e-06	8.39e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	8.63e-06	8.37e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.53e-06	8.28e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	8.52e-06	8.27e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.52e-06	8.27e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	8.5e-06	8.25e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	8.37e-06	8.13e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.37e-06	8.13e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.35e-06	8.11e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.35e-06	8.11e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.35e-06	8.11e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.35e-06	8.11e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.32e-06	8.08e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	8.27e-06	8.03e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.23e-06	7.99e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.23e-06	7.99e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.18e-06	7.94e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	8.17e-06	7.93e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.03e-06	7.79e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	8.03e-06	7.79e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.01e-06	7.77e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	7.91e-06	7.68e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	7.89e-06	7.66e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	7.89e-06	7.66e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	7.85e-06	7.62e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	7.84e-06	7.61e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	7.69e-06	7.47e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	7.56e-06	7.34e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	7.56e-06	7.34e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.48e-06	7.26e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.46e-06	7.25e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.45e-06	7.24e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	7.45e-06	7.23e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.44e-06	7.22e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.33e-06	7.12e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	7.32e-06	7.11e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.3e-06	7.09e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.3e-06	7.09e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	7.3e-06	7.08e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.22e-06	7.01e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	7.22e-06	7.01e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.22e-06	7.01e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	7.21e-06	7e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	7.18e-06	6.97e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.09e-06	6.88e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.95e-06	6.74e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	6.92e-06	6.72e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.89e-06	6.69e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.88e-06	6.68e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.81e-06	6.61e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.81e-06	6.61e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	6.8e-06	6.6e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.8e-06	6.6e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	6.77e-06	6.57e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.69e-06	6.5e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	6.68e-06	6.48e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.68e-06	6.48e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.63e-06	6.44e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.63e-06	6.44e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.63e-06	6.44e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.59e-06	6.4e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.57e-06	6.38e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.52e-06	6.33e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.48e-06	6.29e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.47e-06	6.28e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.43e-06	6.24e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.41e-06	6.22e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.4e-06	6.21e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	6.36e-06	6.17e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.31e-06	6.12e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.24e-06	6.06e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	6.24e-06	6.06e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	6.24e-06	6.05e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.19e-06	6.01e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.16e-06	5.98e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.14e-06	5.96e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.06e-06	5.88e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.04e-06	5.86e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.04e-06	5.86e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.03e-06	5.85e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.01e-06	5.83e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.95e-06	5.78e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.95e-06	5.78e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.95e-06	5.78e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.92e-06	5.74e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.88e-06	5.71e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.84e-06	5.67e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.81e-06	5.64e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.8e-06	5.63e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.79e-06	5.62e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.73e-06	5.56e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	5.72e-06	5.55e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.66e-06	5.5e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.62e-06	5.46e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.57e-06	5.41e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.53e-06	5.36e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.51e-06	5.35e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.47e-06	5.31e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.47e-06	5.31e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.47e-06	5.31e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	5.47e-06	5.31e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	5.47e-06	5.31e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.44e-06	5.28e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.44e-06	5.28e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.38e-06	5.22e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.38e-06	5.22e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.3e-06	5.14e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.21e-06	5.06e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.19e-06	5.04e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.16e-06	5.01e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.16e-06	5.01e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.15e-06	5e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.13e-06	4.98e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	5e-06	4.85e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.8e-06	4.66e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.7e-06	4.57e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.69e-06	4.55e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.65e-06	4.51e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.62e-06	4.48e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.52e-06	4.39e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.45e-06	4.32e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.45e-06	4.32e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.43e-06	4.3e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.43e-06	4.3e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.39e-06	4.26e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.37e-06	4.24e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.34e-06	4.22e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.31e-06	4.19e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.26e-06	4.13e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.24e-06	4.12e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.13e-06	4.01e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.13e-06	4.01e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.12e-06	4e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.06e-06	3.95e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.05e-06	3.93e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.05e-06	3.93e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.96e-06	3.85e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.95e-06	3.83e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.94e-06	3.83e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.89e-06	3.77e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.89e-06	3.77e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.85e-06	3.73e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.8e-06	3.69e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.77e-06	3.66e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.64e-06	3.54e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.62e-06	3.51e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.58e-06	3.47e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.56e-06	3.45e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.55e-06	3.44e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	3.48e-06	3.38e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.46e-06	3.36e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.41e-06	3.31e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.39e-06	3.29e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.35e-06	3.26e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.96e-06	2.87e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.9e-06	2.81e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.73e-06	2.65e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.66e-06	2.58e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.54e-06	2.47e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.54e-06	2.47e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.52e-06	2.44e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.51e-06	2.44e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.32e-06	2.26e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.9e-06	1.84e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.79e-06	1.73e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	1.13e-05	CbGpPWpGaD
